1. Volume 95, Issue 2, Pages 429-438 (February 2019)
Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies 
Shane A. Bobart, An S. De Vriese, Aditya S. Pawar, Ladan Zand, Sanjeev Sethi, Callen Giesen, John C. Lieske, Fernando C. Fervenza 
Kidney International 
Volume 95, Issue 2, Pages (February 2019)
DOI: /j.kint
Copyright © 2019 International Society of Nephrology Terms and Conditions

2. Kidney International 2019 95, 429-438DOI: (10.1016/j.kint.2018.10.021)
Copyright © 2019 International Society of Nephrology Terms and Conditions

3. Figure 1
Patients testing positive for phospholipase A2 receptor (PLA2R) antibodies. CA, cancer; CXR, chest x-ray; eGFR, estimated glomerular filtration rate; ELISA, enzyme-linked immunosorbent assay; IFA, immunofluorescence assay; NSAIDs, nonsteroidal antiinflammatory drugs; PSA, prostate-specific antigen.
Kidney International  , DOI: ( /j.kint )
Copyright © 2019 International Society of Nephrology Terms and Conditions

4. Figure 2
Algorithm for centers preferentially performing immunofluorescence assays (IFAs). This applies only in the event of preserved renal function and absence of secondary causes of membranous nephropathy (MN). ag, antigen; ELISA, enzyme-linked immunosorbent assay; PLA2R, phospholipase A2 receptor; RU, relative units; THSD7A, thrombospondin type-1 domain containing 7A.
Kidney International  , DOI: ( /j.kint )
Copyright © 2019 International Society of Nephrology Terms and Conditions

5. Figure 3
Algorithm for centers preferentially performing enzyme-linked immunosorbent assays (ELISAs). This applies only in the event of preserved renal function and absence of secondary causes of membranous nephropathy (MN). ag, antigen; PLA2R, phospholipase A2 receptor; RU, relative units; THSD7A, thrombospondin type-1 domain containing 7A.
Kidney International  , DOI: ( /j.kint )
Copyright © 2019 International Society of Nephrology Terms and Conditions